No Way To Go But Grow: J&J Outlines Plans To Become A $60bn Pharma In 2025

Nov 18 2021

• By Jessica Merrill

J&J outlined growth plans for its Janssen pharmaceutical unit • Source: Alamy

More from Strategy

More from Business